Aster Capital Management (Difc) LTD Royalty Pharma PLC Transaction History
Aster Capital Management (Difc) LTD
- $198 Billion
- Q3 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 6,601 shares of RPRX stock, worth $262,257. This represents 0.12% of its overall portfolio holdings.
Number of Shares
6,601Holding current value
$262,257% of portfolio
0.12%Shares
4 transactions
Others Institutions Holding RPRX
# of Institutions
522Shares Held
285MCall Options Held
1.67MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.85 Billion0.11% of portfolio
-
Capital International Investors Los Angeles, CA27.2MShares$1.08 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY23MShares$914 Million0.01% of portfolio
-
Baillie Gifford & CO17.4MShares$690 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$485 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...